Virupaksha Organics Ltd. has emerged as a leader in the pharmaceutical industry, specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs). Founded in 2003, the company has built a reputation for innovation, quality, and sustainability. Under the dynamic leadership of Mr. Chandra Mouliswar Reddy Gangavaram, Virupaksha has grown its operations significantly, with state-of-the-art manufacturing facilities in Telangana, India.
The company’s facilities in Kazipally and Pashamylaram are certified by international and national regulatory bodies, including ISO 9001, ISO 14001, ISO 45001, ISO 50001, and GMP standards, ensuring that Virupaksha meets the highest levels of quality and safety in its production processes. These certifications highlight the company’s commitment to environmental sustainability, occupational safety, and best industry practices.
Virupaksha Organics is committed to excellence, innovation, and customer satisfaction, with a focus on developing sustainable solutions for the pharmaceutical industry. The company’s products are trusted by major pharmaceutical firms globally, as it continues to make strides towards becoming a research-driven organization. With a forward-thinking management team and a clear vision for the future, Virupaksha Organics is poised for rapid growth and continues to play a key role in advancing global healthcare.
As part of its corporate social responsibility (CSR), Virupaksha has initiated numerous welfare programs aimed at uplifting local communities and supporting environmental conservation, reinforcing its reputation as a responsible corporate citizen.
With continuous advancements and strategic partnerships, Virupaksha Organics Ltd. is well-positioned to expand its global footprint and contribute to the evolving pharmaceutical landscape.
Other Latest News
- LTTE: Area Resident Concerned About MVNH WW Discharge of Big Pharma The Piedmont Journal Record - Virginia By news@madrapp.org | on June 12, 2026 Editor’s Note: This letter was sent to Virginia DEQ as written comment regarding the Mountain View Nursing Home’s wastewater discharge permit renewal currently under consideration. Mountain View Nursing Home …
- Marco Pharma International appears on the Enterprise Podcast Network WFMZ - Pennsylvania Director of Operations Isaac Conyers IV discusses the company's practitioner-focused model and 35-year history ROSEBURG, Ore., June 12, 2026 /PRNewswire/ -- Marco Pharma International, a family-owned distributor of German biological medicines, …
- Parents paying up to $20K to inject children with autism with unauthorized treatment touted by RFK Jr. AOL NEED TO KNOW Clinics in multiple states are offering unapproved stem cell treatments for autism, costing families up to $20K per session The FDA warns these treatments are unproven and potentially harmful to patients Families, desperate for help, are …
- Durham Poet Arielle Hebert On Writing About Girlhood, Addiction, and the Mixed Magic of Florida INDY Week - North Carolina Bottom Feeders release party | Friday, June 26, 6:30 p.m. | Letters Bookshop, Durham “I don’t think I’ll ever stop writing about Florida,” said Arielle Hebert, author of new poetry collection Bottom Feeders, speaking from a Durham office crowded with lush- …
- Investment in tech research welcomed, with reservations University World News IRELAND A €450 million (approximately US$520.5 million) investment by the Irish government in seven advanced tech research centres has been welcomed by university leaders but treated with reservations and even distrust by a significant number of faculty …
- A Peter Thiel-Backed Tribunal Is Putting Journalists on Trial. I’m Its First Target The Hollywood Reporter - California For many journalists, blowback is just part of the business. The irate call to the editor or publisher, often expressed through the promise of litigation. The online pile-on, often expressed through personal invective. Occasionally, the threat of violence …
- 'Not a great environment for Indian market': Harsha Upadhyaya on Iran-US tensions, IT outlook, pharma bet, and where to be cautious The Economic Times With West Asia tensions flaring again, US inflation at a three-year high, and the Fab-7 tech giants starting to crack, the global environment has turned markedly less friendly for Indian equities. Harsha Upadhyaya, Chief Investment Officer – Equity and …
- Cinde Warmington may be Democrats’ only choice for governor. Do they want her? Concord Monitor - New Hampshire Sign up for the Concord Monitor’s morning newsletter for essential news each day, and our contests and promotions list for special offers and giveaways. As Marci Stone saw the weeks pass by and the 2026 elections approaching with just one Democrat running …
- Hate Big Pharma all you like, it still might save your life Washington Examiner In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to give readers the full picture. You can find our full list …
- He profits off raw milk that makes people sick as government... People's World Raw Milk| AP A white Ford pickup truck broke through a thick curtain of fog one morning in February, winding its way down a muddy farm road in California’s Central Valley. From it emerged a 64-year-old dairyman, burly and tan, who left the engine running …
- Business News | Piyush Goyal Discusses TEPA Implementation, Swiss Pharma Investments During Switzerland Visit Latestly Commerce Minister Piyush Goyal with Swiss President Guy Parmelin in Switzerland on Friday (Photo/X@PiyushGoyal) Berne [Switzerland], June 12 (ANI): Union Commerce and Industry Minister Piyush Goyal on Friday began his two-day visit to Switzerland with …
- Sensex today | Stock Market Highlights: Sensex, Nifty surge nearly 2% as falling oil prices lift market sentiment The Hindu Business Line Sensex Today, Nifty 50 | Stock Market Highlights - Find here all the live updates related to Sensex, Nifty, BSE, NSE, share prices and Indian stock markets for 12th June 2026 Sensex closed 1,695 points higher at 75,527, while the Nifty gained 461 points to …
- Politics Insider: U.S. open to trade deal offers, Hoekstra says The Globe and Mail Hello, welcome to Politics Insider. Let’s look at what happened today. U.S. President Donald Trump’s comment that he is not looking to renew the continental trade agreement is actually an invitation to make a deal, the U.S. ambassador to Canada says. …
- Illinois distributes first $25M to local pharmacies to help them compete NPR Illinois CHICAGO — Gov. JB Pritzker announced Friday that 434 Illinois pharmacies will receive nearly $25 million in support, the first distribution of annual funding established through legislation he signed last year. The fund was designed to assist pharmacies …
- <![CDATA[Why Some Employers Are Scaling Back GLP-1 Coverage in 2027]]> Pharmaceutical Commerce A new survey from Business Group on Health confirms what benefits managers have been anticipating for months: nearly eight in 10 employers report that GLP-1s are driving an increase in their company's overall health care costs, and the financial …
- India Sends 20,000 Vaccine Doses, 3 Tonnes Of Medical Aids To Maldives Over Meales Cases ABP Live Show Quick Read Key points generated by AI, verified by newsroom India dispatched 20,000 measles vaccines and medical supplies to Maldives. This aid addresses rising measles cases, strengthens immunization coverage. Maldives appreciated India's timely …
- Ascendis' TransCon PTH Sustains Long-Term Benefits In Hypoparathyroidism Patients RTTNews Ascendis Pharma A/S (ASND) has reported five-year Phase 2 data showing that its TransCon PTH (palopegteriparatide) consistently replicated the systemic actions of natural parathyroid hormone in adults with hypoparathyroidism, sustaining efficacy and …
- Weekly Buzz: GH, LLY Gain FDA Nod; TEVA, GSK, Lead M&A Wave; ZEAL, LLY Post Strong Data RTTNews This week, the biotech sector saw a surge of FDA, EU, and China approvals spanning oncology, dermatology, autoimmune and rare disease indications. Strategic acquisitions and licensing deals drove pipeline expansion, while positive clinical readouts in …
- Novartis’ $12B Avidity buy pays dividends with Phase 1/2 muscular dystrophy win BioSpace Novartis’ $12 billion gambit for Avidity Biosciences late last year is starting to pay off, with the pharma reporting promising biomarker findings for its investigational RNA medicine in patients with facioscapulohumeral muscular dystrophy. In the Phase 1…
- Meet The NY-17 Democratic Candidates: Cait Conley River Journal - New York <figure id="attachment_303788" aria-describedby="caption-attachment-303788" style="width: 297px" class="wp-caption alignleft"><img decoding="async" class="size-medium wp-image-303788" src …
- Chinese Pharma Giant WuXi AppTec Sues Pentagon Over Blacklisting Asia Financial Chinese pharmaceutical firm WuXi AppTec asked a US court on Thursday to overturn its recent addition to a Pentagon blacklist of companies believed to be aiding Beijing’s military. In a lawsuit filed in federal court in Washington, the company alleged …
- Novo hit with cybersecurity breach, urges vigilance among trial participants BioSpace Novo Nordisk has suffered a cybersecurity breach involving what the pharma called “unauthorized access” to their trial participants’ personal data. The severity and breadth of the breach remain unclear, but Novo in a news release on Thursday said that only …
- US legislation targets China pharma IP licensing following multi-billion Pfizer, BMS deals Intellectual Asset Management A meteoric rise in Sino-American IP-driven dealmaking risks intervention by policymakers Register for limited access Register to receive our newsletter and gain limited access to subscriber content. Register now Subscribe to unlock unlimited access Get …
- Healthcare Triangle, Inc. Announces Closing of Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of Approximately $3.6 Million Prince George Post Breadcrumb Trail Links PR Newswire PLEASANTON, Calif., June 12, 2026 /CNW/ — Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions for healthcare and life sciences, today announces the …
- Silent health risks affecting South African men may go undetected for years Germiston City News This Men’s Health Month, experts are warning that millions of people may be living with early-stage heart, kidney and metabolic conditions without knowing it. New international research shows that early heart dysfunction often goes undiagnosed, a concern …
- Novo Nordisk comeback stirs as Wegovy pill wins UK approval Pharmaceutical Technology The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s Wegovy (semaglutide) pill, marking another regulatory win for the drugmaker as it looks to close the gap to obesity market rival Eli Lilly. The agency has …
- Abridge Goes Beyond Documentation: 4 Updates MedCity News Clinical AI startup Abridge is one of the most well-funded health tech startups in the nation, having raised $1.1 billion since its founding in 2018. On Thursday, the startup held an event in New York City to demonstrate how it’s been putting those funds …
- Podcast: Championing the next generation of life sciences talent, a NIHR perspective Clinical Trials Arena With so much innovation happening within the life sciences sector, now is arguably the perfect time for new faces to join the industry. However, at the 2026 13th Annual Outsourcing in Clinical Trials UK and Ireland conference, held in London from 9-10 June …
- Business News | AI Risk Intelligence Startup Privue Raises Angel Round to Expand Dealer Intelligence Application Latestly VMPL New Delhi [India], June 12: Privue, a startup focused on AI-powered risk intelligence for enterprises, has raised an angel round of funding. The round saw participation from owners of large manufacturing companies, along with senior leaders from real …
- I Figured Out How to Rig Rotten Tomatoes Prediction Markets Intelligencer - New York Photo-Illustration: Intelligencer; Photos: Getty Insider trading used to be the domain of mergers and acquisitions lawyers, bankers in contrast collars, and Martha Stewart — people with influence using tips from their station in life to win while people on …
- [CAGR of 6.2%] Paraben Market Size, Share, Latest Exclusive Report, 2031 EIN Presswire The global paraben market is projected to reach $164.8 million by 2031, growing at a CAGR of 6.2% from 2022 to 2031. WILMINGTON, DE, UNITED STATES, June 12, 2026 /EINPresswire.com/ -- According to the report published by Allied Market Research …
- Opening Bell: Can Bulls Extend Gains? Sensex Jumps 700 Pts, Nifty Above 23,300 News X 77 Stock Market Today | Opening Bell: If you were looking for a strong finish to the week on Dalal Street, Friday morning has provided just that. The Indian stock market has begun the last trading session of the week on a strong note as investors once …
- Insurers Aren’t the Villain of the Health Care System The Daily Economy In a post last week, I wrote about the progressive anti-monopoly movement’s increasing disconnect from reality. I wrote: [C]onsider the movement’s choice of targets. These include some industries with high profit margins, but also some with very low …
- How did Prega News achieve an 85% market share in India’s pregnancy kit industry? Afaqs For just Rs 60, Indian women can determine whether their missed period warrants a visit to a gynaecologist or a trip to the toy store, thanks to Prega News’ home pregnancy detection kit. Not all pregnancies are celebrated, though; some women are also …
- 5-Year Phase 2 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH in Adults with Hypoparathyroidism EIN Presswire – Multi-organ system and quality-of-life benefits sustained through five years of treatment – 82% response rate for the multi-component endpoint – 95% of patients completed five years of treatment COPENHAGEN, Denmark, June 11, 2026 (GLOBE NEWSWIRE) -- …
- Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio EIN Presswire Doc Pharma financial profile: approximately $24 million asset base, approximately $6.7 million in average annual revenue and approximately $3.2 million in average annual gross profit. Immediately accretive: expected to support margin expansion, …
- Buried Before Ivermectin: Meet Chlorine Dioxide Brownstone I always knew that corruption existed in every field. I assumed that when it came to Big Pharma, the same was true, but I thought of it as something abstract: an inflated contract here, an outrageously profitable deal there, an abusive markup somewhere …
- <![CDATA[Pharma Pulse: A Surge In Drug Discontinuations and Unapproved Retatrutide Prescriptions]]> Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast bringing you the latest insights shaping patient access, regulatory policy, and healthcare innovation. I'm your host, and let's get into today's headlines. First up, a new annual drug …
- Medicus Pharma Initiates Groundbreaking PRECISION-E2 Phase 2a Study of Teverelix® in Endometriosis utilizing the Emirati Genome Program EIN Presswire PHILADELPHIA, June 11, 2026 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) (“Medicus” or the “Company”), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutic …
- Helus Pharma to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Conference EIN Presswire NEW YORK and TORONTO, June 11, 2026 (GLOBE NEWSWIRE) -- Helus PharmaTM (Nasdaq: HELP) (Cboe CA: HELP), a clinical-stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), today announced that Amir …
- Sun Pharma sets record, payment dates for FY26 final dividend Business Today Sun Pharmaceutical Industries Ltd, the country's largest pharma company, on Thursday announced record and payment dates for the final dividend payment of Rs 5 per share for the financial year 2025-26 (FY26). It has fixed July 7, 2026, as the record …
- World News | Jaishankar Holds Talks with Bulgarian PM, Foreign Minister to Deepen Strategic Partnership Latestly Sofia [Bulgaria], June 10 (ANI): External Affairs Minister S Jaishankar on Wednesday held high-level talks with Bulgarian leaders, including Prime Minister Rumen Radev and Foreign Minister Velislava Petrova-Chamova, focusing on expanding bilateral …
- Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons EIN Presswire Company announcement – No. 24 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, June 10, 2026 – Zealand Pharma …
- World News | Piyush Goyal Meets Ernst & Young CEO, Discusses India's Role in Global Supply Chains Latestly New Delhi [India], June 10 (ANI): Union Minister Piyush Goyal held a meeting with Janet Truncale, Global Chair and CEO of Ernst & Young (EY), to discuss India's growing role in global supply chains and the expanding opportunities in Global …
- Billionaire Stanley Druckenmiller Likes This Small-Cap Pharma Stock in 2026 Yahoo Finance We just covered the 10 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller. NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) ranks #5 (see 5 Best Non-AI Stocks to Buy According to Billionaire Stanley Druckenmiller). Druckenmiller’s Stake …
- This Week’s Biopharma News: Big Moves in Bispecifics The Medicine Maker Ivonescimab beats PD-1 plus chemo in first-line squamous NSCLC Akeso’s ivonescimab, a first-in-class PD-1/VEGF bispecific antibody, has improved overall survival versus PD-1 plus chemotherapy in patients with advanced squamous non-small cell lung …
- Business News | Himachal Government Clears 42 Investment Proposals Worth Rs 5,877 Crore; over 13,000 Employment Opportunities Expected Latestly Shimla [Himachal], June 9 (ANI): The Himachal Pradesh Government has approved investment proposals of Rs. 5877.01 crore that can generate over 13,000 employment opportunities in the state. The decision was taken in the 32nd Meeting of the State Single …
- <![CDATA[Deepening Ties: Why China is Becoming Big Pharma's Most Essential R&D Partner]]> Pharmaceutical Executive The pace and scale of the pharma industry’s turn toward China in early 2026 is difficult to overstate, with more than $43 billion in licensing commitments in just five months. What is currently unfolding can be described as a structural realignment of …
- <![CDATA[Pharma Funding Roundup: City Therapeutics Closes $99.5 Million Series B, Eloxx Pharmaceuticals Announces Pricing of $66 Million Public Offering ]]> Pharmaceutical Executive Two RNA-focused biotechs secured fresh capital this week, as City Therapeutics closed a $99.5 million Series B to advance its RNAi pipeline and Eloxx Pharmaceuticals raised $66 million in a public offering tied to its Nasdaq uplisting. City Therapeutics …
- Chinese pharma contractor under watch: Pentagon names WuXi AppTec on military list The Print WuXi AppTec Co. will face fresh questions about its growth prospects after the Pentagon named the major pharmaceutical contractor on a list of firms associated with the Chinese military, a move that could also complicate research being done by American …